companies making glp-1 drugs 2.0: Where the Next Wave of Value Will Be Created GLP-1 Drugs from the Gray
Description
DOI: 10.7759/cureus.87823, Mansour, A., Sajjadi-Jazi, S
Semaglutide, known by brand names such as Wegovy for weight management and Ozempic for type 2 diabetes, functions as a GLP-1 receptor agonist
4,887 participants treated with tirzepatide and 2,328 control participants were analyzed and 142 participants had at least one MACE-4 event
A retrospective analysis of the DURATION trials found that overall, greater weight loss was associated with gastrointestinal adverse events with exenatide once weekly and exenatide twice daily
Do I have any contraindications
contributing by generating constructs and collecting and processing raw data for this experiment
